Global Health NOW Submission Guidelines: Pitching Global Health Opinion

Key takeaways

• Global Health NOW (GHN), the news service published by the Johns Hopkins Bloomberg School of Public Health, runs opinion pieces of roughly 700 to 900 words that make one timely, evidence-backed argument.
• Editors judge the pitch first. A pitch that names the news hook, states the argument in one sentence, and explains the author's direct expertise gives an editor a reason to say yes quickly.
• GHN fits practitioners, clinicians, and researchers who can react to a report, vote, or outbreak within days and write in plain language. It fits long technical analyses poorly.
• Authors based in low- and middle-income countries and frontline workers are actively welcome, and funding sources or conflicts of interest must be disclosed.
• Several other venues take similar commentary at different lengths and speeds, so matching the outlet to the piece matters as much as writing it well.

1. Introduction

Global health produces new evidence constantly: WHO reports, outbreak data, funding decisions, conference votes. The public debate about that evidence happens largely in commentary, and for many people in the field, Global Health NOW is where that commentary appears. The outlet's free newsletter reports readers in more than 200 countries, and its opinion section gives practitioners a route into debates that journals reach slowly and general newsrooms cover thinly.

Most pitches fail on predictable grounds. Writers summarize a topic without taking a position. They pitch weeks after the news cycle has passed. They bury their own authority. The Global Health NOW submission guidelines are short, which leaves many would-be contributors guessing at what editors want.

This article covers three things: what GHN publishes and who benefits from writing there; how to build a pitch an editor can evaluate in under a minute; and how GHN compares with other outlets that take global health opinion, so you can place a piece where it will do the most work.

2. What Global Health NOW is and who it fits

GHN is a fast, credible venue for short, timely commentary, and it rewards authors with direct experience of the problem they describe.

The outlet is produced by the Johns Hopkins Bloomberg School of Public Health, which gives it institutional standing that most blogs and program websites lack. Its newsletter reaches a professional audience: students, program staff, policymakers, funders, journalists. An opinion piece there is read by people who allocate budgets and design programs, which changes what a 900-word argument can accomplish.

Strengths:

• Speed. Timely pieces can move from pitch to publication within days, which matters when a vote or a report is live.
• Audience fit. Readers work in global health, so you can name institutions and programs after defining them once.
• Editorial attention. The opinion desk works with authors on framing and cuts, which helps early-career writers.
• Reach outside the usual circles. GHN has pushed consistently for authorship from low- and middle-income countries, including a dedicated Local Voices program for columnists based there.

Limitations:

• Length. At roughly 700 to 900 words, an op-ed carries one argument and a few examples. A 30-page analysis will not fit.
• Shelf life. Commentary tied to a news event ages within weeks.
• Competition. Opinion slots are few relative to pitch volume, and competent submissions get declined for space alone.
• No promotional content. Program marketing or funder messaging dressed up as opinion will not run, and undisclosed conflicts end a relationship with the desk.

The outlet fits early- to mid-career researchers, clinicians, program managers, and policy staff who have seen the issue from inside. Authors based in Africa, Asia, and Latin America get a platform with an international professional readership, which is a practical reason to pitch GHN when the argument concerns decisions made in Geneva, Washington, or Brussels.

Scenario: a district health officer in Kenya watches a donor procurement change interrupt antiretroviral supply. She can pitch within 48 hours with one argument and two examples from her own clinics. That pitch has a real chance. The same officer with a 9,000-word program evaluation should place it elsewhere, or strip it to a single finding and pitch that.

3. How to build a pitch the editors can say yes to

The pitch is the piece in miniature. If the argument is not visible in the first two sentences, the editor has already moved on.

Opinion editors evaluate pitches on three questions: what is the argument, why now, and why this person. A pitch that answers all three in a few paragraphs lets an editor decide without requesting revisions. A pitch that answers none of them forces the editor to imagine the piece, and most will decline instead.

A workable pitch contains:

• A subject line that names the topic and the stance. "Op-ed pitch: the new TB funding targets will fail without community diagnosis" tells the editor more than "op-ed submission" does.
• The argument in one sentence, placed first.
• The news hook: the report release, the World Health Assembly vote, the anniversary, the new data. If no hook exists, the piece belongs in a slower venue.
• Why you: your role, your region, and what you have seen or measured yourself. One line on any funding tied to your position.
• Evidence preview: two or three specific facts, figures, or examples the piece will use, with their sources.
• Logistics: target length (around 800 words fits GHN's stated range), when you can deliver, and whether the piece has appeared anywhere else.

In this form, a pitch can run under 250 words:

Subject: Op-ed pitch: the malaria vaccine rollout will stall without funding for nurses

I manage immunization programs for a network of 40 clinics in western Uganda. The first malaria vaccine doses reached our district this year, and rollout decisions are being made without the people who administer them. My argument: countries are budgeting for vaccines and treating the nursing workforce as an afterthought, which repeats the pattern we saw with COVID-19 boosters. I can cite WHO rollout figures, our own clinic data, and the staffing gaps in the national deployment plan. I can deliver 800 words within a week. The piece is unpublished, and I have no funding ties to vaccine manufacturers.

Three cautions:

• Check the current guidelines page for the submission channel and follow it. Addresses change, and a pitch to a stale inbox is a pitch to nobody.
• If the piece is time sensitive, follow up once after a few business days. Silence usually reflects volume, and a short nudge can rescue a piece the editor meant to read.
• Tell each editor if you have pitched the piece elsewhere. When an editor commits time and the piece lands somewhere else, that relationship is spent.

4. Writing the op-ed after acceptance

Accepted pitches still fail in drafting when the author buries the position. Write so that a reader can state your argument after the first paragraph.

Newsletter readers skim, and GHN's guidance asks for plain language. Editors will cut jargon, acronyms, and hedging. The piece also has to survive the gap between your expertise and the reader's: details that feel obvious to you are often the ones that convince someone outside your field.

Structure that works:

1. Open with the stake and the position in one or two paragraphs. Name the decision at risk.
2. Support the argument with evidence: one strong statistic, one example from your own work, and what studies or reporting show. One number a reader can repeat does more than five numbers a reader skips.
3. Close with a recommendation addressed to a named actor: the delegates at the next World Health Assembly, a specific donor board, a ministry of health. "Something must be done" is a summary. "The Global Fund board should tie the next replenishment to community-level diagnostic budgets" is an argument.

Practical notes:

• Expect edits. Editors set the headline, may trim 150 words to fit a news cycle, and will push back on claims you cannot support. Fast agreement protects the publication date.
• Disclose what a reader needs to know: funding sources, advisory roles, employer positions on the issue. Disclosure belongs in the piece or the author bio, and GHN's guidelines expect it.
• Use first person when your experience is the evidence. Field detail carries authority that citations alone cannot supply, and it separates your piece from a research summary anyone could write.

Pieces get declined or die in editing for a short list of reasons: the draft summarizes without stating a position, the topic is too broad for 800 words, the author's connection to the subject is unclear, the timing hook expired during review, or the piece reads as marketing for a program, product, or funder.

5. Comparing venues: where a global health opinion lands

GHN is one of several realistic targets, and the right choice depends on length, speed, and who needs to read the piece.

Choose by situation. A reaction to a report or vote within 48 hours goes to GHN. A developed policy argument goes to Think Global Health. A clinical practice question goes to BMJ Opinion. A data-heavy claim with academic weight goes to The Lancet. Aid sector politics goes to Devex. An argument centered on technology governance, such as regulation of diagnostic algorithms, fits the technology policy venues in the table. The same evidence can travel to several of these outlets only if you rewrite it for each one's length and audience, and only with each editor told where else it has been.

6. FAQ

Q1. How long should a Global Health NOW op-ed be?

The Global Health NOW submission guidelines call for opinion pieces in the range of roughly 700 to 900 words, so target about 800. A pitch can be much shorter; 150 to 250 words is enough to carry an argument, a hook, and your credentials. A full draft sent instead of a pitch should respect the same length range before you submit.

Q2. Can students or early-career professionals submit?

Yes. GHN has published students and early-career contributors, and its guidance asks for expertise or direct experience rather than seniority alone. State your role and what you have seen or measured. If your argument depends on institutional access, explain the access. Disclosure rules for funding and conflicts apply to every author regardless of career stage.

Q3. Should I send a pitch or a finished draft?

Both are accepted, and the choice is practical. A short pitch protects your time on a fast-moving story, because the editor can confirm interest before you draft. A finished draft makes sense when the argument took months to build and only you can assemble it. Check the guidelines page for the current submission channel either way.

Q4. What should I do after a rejection?

Read the decline for information; some replies name the reason, such as overlap with a piece already in the pipeline. If no reason is given, the likely causes are timing, a missing argument, or unclear expertise. Tighten the argument to one sentence, add a stronger hook, or move the piece to a better-fit venue from the comparison above, and revise before submitting anywhere else.

7. Conclusion

A pitch to Global Health NOW is worth the work when three things are true: you hold one clear position, a live news event gives it a reason to run now, and your own experience explains why readers should hear it from you. The pitch should carry all three in its first two sentences, and the draft should hold them in place with evidence and a named recommendation. When one of the three is missing, the comparison table above points to venues that match what the piece actually is, and placing it there does more for the argument than forcing it into 800 words. Before writing anything, check the current Global Health NOW guidelines page for length, submission channel, and disclosure requirements, then time the pitch to the event that makes it matter.